DCI D-Chiro-Inositol
Natural health product licensed in Canada
- Licence holder
- Chiral Balance LLC
- NPN or DIN-HM
- 80070490
- Status
- Active licence
- Licence date
- 21 June 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| D-Chiro-inositol Source : D-Chiro-inositol | 600 milligramme | Not calculated |
Non-medicinal ingredients
Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Aids in the management of polycystic ovarian syndrome (PCOS) by helping restore normal ovarian function. Helps to reduce serum testosterone in women with PCOS. Helps promote normal ovulation in those with polycystic ovarian syndrome. Aids in the management of the symptoms associated with polycystic ovarian syndrome's (PCOS) metabolic features by promoting healthy glucose metabolism, helping support healthy cholesterol levels, and helping reduce plasma triglyceride levels. Aids in the management of the symptoms associated with polycystic ovarian syndrome's (PCOS) reproductive features including hyperandrogenism, hirsutism, and menstrual dysfunction by helping reduce serum testosterone and helping promote normal ovulation. Aids in the management of polycystic ovarian syndrome (PCOS) by reducing oxidative damage (to follicular fluid proteins).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
For adults only. If symptoms persist or worsen, consult your healthcare practitioner. To ensure the timely treatment of a serious cause of infertility, consult a healthcare practitioner prior to use. Consult a health care practitioner prior to use if you are pregnant or breastfeeding.
Source
Official Health Canada record, licence 80070490
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.